Increased Risk of Sudden Cardiac Arrest in Obstructive Pulmonary Disease: A Case-Control Study

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Warnier, Miriam Jacoba ^a,b   Blom, Marieke Tabo ^c   Bardai, Abdennasser ^c,d   Berdowksi, Jocelyn ^c   Souverein, Patrick Cyriel ^a   Hoes, Arno Wilhelmus ^b   Rutten, Frans Hendrik ^b   de Boer, Anthonius ^a   Koster, Rudolph Willem ^c   De Bruin, Marie Louise ^a,b   Tan, Han Liong ^c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; LONG ACTING DRUG; SHORT ACTING DRUG;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG USE; FEMALE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; SUDDEN CARDIAC DEATH; AGED; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; LUNG DISEASES, OBSTRUCTIVE; MIDDLE AGED; STATISTICAL MODEL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LOGISTIC MODELS; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84878771668     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065638     Document Type: Article

References (43)

1. Myerburg RJ, Castellanos A (2007) Cardiac arrest and sudden cardiac death. In: Libby P, Bonow RO, Mann DL, Zipes DP, editors. Braunwald's Heart Disease: A textbook of cardiovascular medicine. Elsevier; 933-74.
2. Hua W, Zhang LF, Wu YF, Liu XQ, Guo DS, et al. (2009) Incidence of sudden cardiac death in china: Analysis of 4 regional populations. J Am Coll Cardiol 54: 1110-1118.
3. Berdowski J, Berg RA, Tijssen JG, Koster RW, (2010) Global incidences of out-of-hospital cardiac arrest and survival rates: Systematic review of 67 prospective studies. Resuscitation 81: 1479-1487.
4. Nichol G, Thomas E, Callaway CW, Hedges J, Powell JL, et al. (2008) Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA 300: 1423-1431.
5. Blom MT, Warnier MJ, Bardai A, Berdowski J, Koster RW, et al. (2012) Reduced in-hospital survival rates of out-of-hospital cardiac arrest victims with obstructive pulmonary disease. Resuscitation: 'in press'. 10.1016/j.resuscitation.2012.10.009.
6. Sidney S, Sorel M, Quesenberry CP, Jr, DeLuise C, Lanes S, et al. (2005) COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser permanente medical care program. Chest 128: 2068-2075.
7. Han MK, McLaughlin VV, Criner GJ, Martinez FJ, (2007) Pulmonary diseases and the heart. Circulation 116: 2992-3005.
8. Magnussen H, Watz H, (2009) Systemic inflammation in chronic obstructive pulmonary disease and asthma: Relation with comorbidities. Proc Am Thorac Soc 6: 648-651.
9. Wood LG, Baines KJ, Fu J, Scott HA, Gibson PG, (2012) The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma. Chest 142: 86-93.
10. Appleton SL, Ruffin RE, Wilson DH, Taylor AW, Adams RJ, et al. (2009) Cardiovascular disease risk associated with asthma and respiratory morbidity might be mediated by short-acting beta2-agonists. J Allergy Clin Immunol 123: 124-130.e1.
11. Salpeter SR, Ormiston TM, Salpeter EE, (2004) Cardiovascular effects of beta-agonists in patients with asthma and COPD: A meta-analysis. Chest 125: 2309-2321.
12. Singh S, Loke YK, Furberg CD, (2008) Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis. JAMA 300: 1439-1450.
13. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, et al. (2001) Task force on sudden cardiac death of the european society of cardiology. Eur Heart J 22: 1374-1450.
14. Bardai A, Berdowski J, van der Werf C, Blom MT, Ceelen M, et al. (2011) Incidence, causes, and outcomes of out-of-hospital cardiac arrest in children. A comprehensive, prospective, population-based study in the netherlands. J Am Coll Cardiol 57: 1822-1828.
15. Engdahl J, Bang A, Lindqvist J, Herlitz J, (2000) Can we define patients with no and those with some chance of survival when found in asystole out of hospital? Am J Cardiol 86: 610-614.
16. Buurma H, Bouvy ML, De Smet PA, Floor-Schreudering A, Leufkens HG, et al. (2008) Prevalence and determinants of pharmacy shopping behaviour. J Clin Pharm Ther 33: 17-23.
17. Blais L, Suissa S, Boivin JF, Ernst P, (1998) First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma. Thorax 53: 1025-1029.
18. Velthove KJ, Souverein PC, van Solinge WW, Leufkens HG, Lammers JW, (2010) Measuring exacerbations in obstructive lung disease. Pharmacoepidemiol Drug Saf 19: 367-374.
19. Vaughan Williams EM, (1975) Classification of antidysrhythmic drugs. Pharmacol Ther B 1: 115-138.
20. Knol MJ, van der Tweel I, Grobbee DE, Numans ME, Geerlings MI, (2007) Estimating interaction on an additive scale between continuous determinants in a logistic regression model. Int J Epidemiol 36: 1111-1118.
21. Reid DD, Hamilton PJ, McCartney P, Rose G, Jarrett RJ, et al. (1976) Smoking and other risk factors for coronary heart-disease in british civil servants. Lancet 2: 979-984.
22. Sin DD, Wu L, Man SF, (2005) The relationship between reduced lung function and cardiovascular mortality: A population-based study and a systematic review of the literature. Chest 127: 1952-1959.
23. Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, et al. (2007) Resting heart rate in cardiovascular disease. J Am Coll Cardiol 50: 823-830.
24. Jensen MT, Marott JL, Lange P, Vestbo J, Schnohr P, et al. (2012) Resting heart rate is a predictor of mortality in chronic obstructive pulmonary disease. Eur Respir J 'in press'. 10.1183/09031936.00072212.
25. Verrier RL, Tan A, (2009) Heart rate, autonomic markers, and cardiac mortality. Heart Rhythm 6: S68-75.
26. Engstrom G, Wollmer P, Hedblad B, Juul-Moller S, Valind S, et al. (2001) Occurrence and prognostic significance of ventricular arrhythmia is related to pulmonary function: A study from "men born in 1914," malmo, sweden. Circulation 103: 3086-3091.
27. Matsue Y, Suzuki M, Nagahori W, Ohno M, Matsumura A, et al. (2011) Beta-blocker prevents sudden cardiac death in patients with hemodialysis. Int J Cardiol. 'in press'. 10.1016/j.ijcard.2011.09.037.
28. Kendall MJ, Lynch KP, Hjalmarson A, Kjekshus J, (1995) Beta-blockers and sudden cardiac death. Ann Intern Med 123: 358-367.
29. Salpeter SR, (2004) Cardiovascular safety of beta(2)-adrenoceptor agonist use in patients with obstructive airway disease: A systematic review. Drugs Aging 21: 405-414.
30. Teerlink JR, Massie BM, (2000) The role of beta-blockers in preventing sudden death in heart failure. J Card Fail 6: 25-33.
31. Salpeter S, Ormiston T, Salpeter E, (2005) Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (4): CD003566 10.1002/14651858.CD003566.pub2.
32. Engdahl J, Holmberg M, Karlson BW, Luepker R, Herlitz J, (2002) The epidemiology of out-of-hospital 'sudden' cardiac arrest. Resuscitation 52: 235-245.
33. Canto JG, Goldberg RJ, Hand MM, Bonow RO, Sopko G, et al. (2007) Symptom presentation of women with acute coronary syndromes: Myth vs reality. Arch Intern Med 167: 2405-2413.
34. Lipworth BJ, McDevitt DG, (1992) Inhaled beta 2-adrenoceptor agonists in asthma: Help or hindrance? Br J Clin Pharmacol 33: 129-138.
35. Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE, (1990) Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet 336: 1396-1399.
36. Kannel WB, Kannel C, Paffenbarger RS, Jr, Cupples LA, (1987) Heart rate and cardiovascular mortality: The framingham study. Am Heart J 113: 1489-1494.
37. Wong CC, Tong EK, Tsoh JY, Chen M, Hom FB, (2009) Patterns of tobacco-use behavior among chinese smokers with medical conditions. J Community Health 34: 472-479.
38. de Bruyne MC, Hoes AW, Kors JA, Hofman A, van Bemmel JH, et al. (1999) Prolonged QT interval predicts cardiac and all-cause mortality in the elderly. the rotterdam study. Eur Heart J 20: 278-284.
39. Wood-Baker R, Cochrane B, Naughton MT, (2009) Cardiovascular mortality and morbidity in COPD: The impact of bronchodilator treatment. Intern Med J. 40: 94-101.
40. Suissa S, Hemmelgarn B, Blais L, Ernst P, (1996) Bronchodilators and acute cardiac death. Am J Respir Crit Care Med 154: 1598-1602.
41. Celli B, Decramer M, Kesten S, Liu D, Mehra S, et al. (2009) Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 180: 948-955.
42. Michele TM, Pinheiro S, Iyasu S, (2010) The safety of tiotropium-the FDA's conclusions. N Engl J Med 363: 1097-1099.
43. Myerburg RJ, (2001) Sudden cardiac death: Exploring the limits of our knowledge. J Cardiovasc Electrophysiol 12: 369-381.